|
| 35979886 | "I Know That I Was a Part of Making a Difference": Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption. | AIDS Res Hum Retroviruses | 2023 |
| 37837376 | Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States. | HIV Res Clin Pract | 2023 |
| 37291622 | Community engagement group model in basic and biomedical research: lessons learned from the BEAT-HIV Delaney Collaboratory towards an HIV-1 cure. | Res Involv Engagem | 2023 |
| 36975214 | The Natural Stilbenoid (-)-Hopeaphenol Inhibits HIV Transcription by Targeting Both PKC and NF-κB Signaling and Cyclin-Dependent Kinase 9. | Antimicrob Agents Chemother | 2023 |
| 37070542 | Susceptibility to 3BNC117 and 10-1074 in ART suppressed chronically infected persons. | AIDS | 2023 |
| 36963401 | Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis. | Cancer Cell | 2023 |
| 37463049 | The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy. | J Clin Invest | 2023 |
| 36807444 | Tissue injury and leukocyte changes in post-acute sequelae of SARS-CoV-2: review of 2833 post-acute patient outcomes per immune dysregulation and microbial translocation in long COVID. | J Leukoc Biol | 2023 |
| 36460646 | Human galectin-9 promotes the expansion of HIV reservoirs in vivo in humanized mice. | AIDS | 2023 |
| 36799121 | Using a Bioactive <i>Eremophila</i>-Derived Serrulatane Scaffold to Generate a Unique Carbamate Library for Anti-infective Evaluations. | J Nat Prod | 2023 |
| 36657039 | Thorectidiol A Isolated from the Marine Sponge <i>Dactylospongia elegans</i> Disrupts Interactions of the SARS-CoV-2 Spike Receptor Binding Domain with the Host ACE2 Receptor. | J Nat Prod | 2023 |
| 35017208 | The Minority Scientists' Experience: Challenging and Overcoming Barriers to Enhancing Diversity and Career Advancement. | J Immunol | 2022 |
| 35348047 | "We are looking at the future right now": community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States. | HIV Res Clin Pract | 2022 |
| 35730977 | Inhibition of a Chromatin and Transcription Modulator, SLTM, Increases HIV-1 Reactivation Identified by a CRISPR Inhibition Screen. | J Virol | 2022 |
| 35399717 | ONP-302 Nanoparticles Inhibit Tumor Growth By Altering Tumor-Associated Macrophages And Cancer-Associated Fibroblasts. | J Cancer | 2022 |
| 35419694 | Use of hyphenated analytical techniques to identify the bioactive constituents of Gunnera perpensa L., a South African medicinal plant, which potently inhibit SARS-CoV-2 spike glycoprotein-host ACE2 binding. | Anal Bioanal Chem | 2022 |
| 35522580 | Ansellone J, a Potent <i>in Vitro</i> and <i>ex Vivo</i> HIV-1 Latency Reversal Agent Isolated from a <i>Phorbas</i> sp. Marine Sponge. | J Nat Prod | 2022 |
| 35968737 | Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptions | HIV Res Clin Pract | 2022 |
| 35891417 | HPLC-Based Purification and Isolation of Potent Anti-HIV and Latency Reversing Daphnane Diterpenes from the Medicinal Plant <i>Gnidia sericocephala</i> (<i>Thymelaeaceae</i>). | Viruses | 2022 |
| 36220073 | Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapy. | Cancer Cell | 2022 |
| 35916053 | Methadone use is associated with increased levels of sCD14, immune activation, and inflammation during suppressed HIV infection. | J Leukoc Biol | 2022 |
| 35320704 | Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic TÂ cell clones. | Immunity | 2022 |
| 35207719 | Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United States. | J Pers Med | 2022 |
| 33441429 | Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption. | Sci Transl Med | 2021 |
| 33622719 | Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption. | mBio | 2021 |
| 33527127 | Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy. | Clin Infect Dis | 2021 |
| 33577894 | Flavonoid-based inhibition of cyclin-dependent kinase 9 without concomitant inhibition of histone deacetylases durably reinforces HIV latency. | Biochem Pharmacol | 2021 |
| 34543092 | The Natural Stilbenoid (-)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants. | Antimicrob Agents Chemother | 2021 |
| 34447895 | Lack of Atorvastatin Effect on Monocyte Gene Expression and Inflammatory Markers in HIV-1-infected ART-suppressed Individuals at Risk of non-AIDS Comorbidities. | Pathog Immun | 2021 |
| 34188039 | Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV. | Nat Commun | 2021 |
| 34117731 | Immune correlates of therapy outcomes in women with cervical cancer treated with chemoradiotherapy: A systematic review. | Cancer Med | 2021 |
| 34339980 | Design, synthesis and screening of a drug discovery library based on an Eremophila-derived serrulatane scaffold. | Phytochemistry | 2021 |
| 34287839 | BCL6 BTB-specific inhibitor reversely represses T-cell activation, Tfh cells differentiation, and germinal center reaction in vivo. | Eur J Immunol | 2021 |
| 34086344 | Identification of the predominant human NK cell effector subset mediating ADCC against HIV-infected targets coated with BNAbs or plasma from PLWH. | Eur J Immunol | 2021 |
| 34049356 | Comparable HIV suppression by pegylated-IFN-α2a or pegylated-IFN-α2b during a 4-week analytical treatment interruption. | AIDS | 2021 |
| 33436641 | Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy. | Nat Commun | 2021 |
| 33408173 | Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption. | J Virol | 2021 |
| 33449236 | HIV Infection and Depression Among Opiate Users in a US Epicenter of the Opioid Epidemic. | AIDS Behav | 2021 |
| 33323024 | Safety, Immune, and Antiviral Effects of Pegylated Interferon Alpha 2b Administration in Antiretroviral Therapy-Suppressed Individuals: Results of Pilot Clinical Trial. | AIDS Res Hum Retroviruses | 2021 |
| 31571234 | BCL6 BTB-specific inhibition via FX1 treatment reduces Tfh cells and reverses lymphoid follicle hyperplasia in Indian rhesus macaque (Macaca mulatta). | J Med Primatol | 2020 |
| 31972605 | Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint. | AIDS | 2020 |
| 33378668 | Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer. | Cell Rep | 2020 |
| 33239444 | Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1. | Proc Natl Acad Sci U S A | 2020 |
| 33098533 | Correction to: Effect of Opioid Use on Immune Activation and HIV Persistence on ART. | J Neuroimmune Pharmacol | 2020 |
| 33289158 | Persons who inject drugs (PWID) retain functional NK cells, dendritic cell stimulation, and adaptive immune recall responses despite prolonged opioid use. | J Leukoc Biol | 2020 |
| 32690683 | Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA. | Proc Natl Acad Sci U S A | 2020 |
| 32827942 | Interferon-α alters host glycosylation machinery during treated HIV infection. | EBioMedicine | 2020 |
| 32675559 | Hepatitis C virus modulates IgG glycosylation in HIV co-infected antiretroviral therapy suppressed individuals. | AIDS | 2020 |
| 32788215 | The African natural product knipholone anthrone and its analogue anthralin (dithranol) enhance HIV-1 latency reversal. | J Biol Chem | 2020 |
| 32895573 | Recommendations for measuring HIV reservoir size in cure-directed clinical trials. | Nat Med | 2020 |